We are live on
!
Find out more
ORPH
Orphazyme A/S
ORPH
ORPH
Delisted
ORPH was delisted on the 30th of March, 2022.
20 hedge funds and large institutions have $5.77M invested in Orphazyme A/S in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
157% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 7
138% more capital invested
Capital invested by funds: $2.42M → $5.77M (+$3.35M)
122% more funds holding
Funds holding: 9 → 20 (+11)
16% less call options, than puts
Call options by funds: $5.87M | Put options by funds: $7M
Holders
20
Holders Change
+11
Holders Change %
+122.22%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
1
Reduced
–
Closed
7
Calls
$5.87M
Puts
$7M
Net Calls
-$1.14M
Net Calls Change
-$1.14M
Top Buyers
| 1 |
Jane Street
New York
|
+$1.65M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.24M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$864K |
| 4 |
BAM
Blueshift Asset Management
Red Bank,
New Jersey
|
+$574K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$550K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.12M |
| 2 |
Millennium Management
New York
|
-$1.02M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$169K |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
-$40K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$19K |
